Crescent Bioresearch posts MOTS-c lot at 36.6 EU per vial endotoxin
The gray-market supplier's certificate shows the lot passed the testing lab's 40 EU threshold but would fail a stricter 20 EU per vial limit.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 17:28 ETSource: FinancialContent
The wire
- 01BTLabs tested lot CBR-MOT-260403-001 of MOTS-c 40 mg on July 30, 2026 by gel-clot LAL under USP Chapter 85, measuring 36.6 EU per vial against a 40 EU threshold, or 0.92 EU per milligram.
- 02Research-peptide buyers tracking MOTS-c rarely see numeric endotoxin values rather than a bare pass, and the margin matters for anyone working to a tighter internal limit.
- 03This is vendor-published material for a laboratory-use-only compound; the threshold was set by the testing laboratory, not a regulator, and MOTS-c has no approved human indication.
From the source
Read at financialcontent.com36.6 of 40: Crescent Bioresearch MOTS-c Endotoxin Sits 3.4 EU Below Its Limit, a Margin a Pass Alone Would Not Show
MOTS-c lot CBR-MOT-260403-001 measured 36.6 EU per vial against the testing laboratory's threshold of 40 EU per vial, with a lysate sensitivity of 0.25 EU/mL. Against a stricter limit of 20 EU per vial, the same result would not pass.
